Association between Intrapancreatic Fat Deposition and Lower High-Density Lipoprotein Cholesterol in Individuals with Newly Diagnosed T2DM

Table 2

Associations between IFPD and glycemic parameters in 80 individuals with newly diagnosed T2DM.

Parameters	Model 1		Model 2		Model 3
	β (95% CI)		B (95% CI)		B (95% CI)
FBG	0.204 (−0.235, 0.643)	0.358	0.082 (−0.368, 0.533)	0.717	−0.050 (−0.471, 0.371)	0.812
FINS	0.239 (0.036, 0.442)	0.022	0.241(0.037, 0.445)	0.022	0.127 (−0.078, 0.333)	0.221
HbA1c	−0.046(-0.637, 0.545)	0.878	−0.169 (−0.761, 0.422)	0.570	−0.068 (−0.616, 0.481)	0.807
HOMA-IR	0.578 (0.165, 0.990)	0.007	0.535 (0.110, 0.960)	0.014	0.263 (−0.178, 0.704)	0.238
HOMA-β	0.015 (−0.028, 0.059)	0.488	0.021 (−0.023, 0.064)	0.351	0.009 (−0.032, 0.050)	0.663

Regression analysis was used to determine the associations between IPFD and glucose metabolism indicators in individuals with newly diagnosed T2DM. Model 1: unadjusted; model 2: adjustment for age and sex; model 3: adjustment for age, sex, and BMI. FBG, fasting blood glucose; FINS, fasting insulin; HbA1c, hemoglobin A1c; HOMA-IR, homeostasis model assessment of insulin resistance; HOMA-β, homeostasis model assessment of β-cell function. ; .